Literature DB >> 19106390

Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002.

Yangfeng Wu1, Rachel Huxley, Liming Li, Vibeke Anna, Gaoqiang Xie, Chonghua Yao, Mark Woodward, Xian Li, John Chalmers, Runlin Gao, Lingzhi Kong, Xiaoguang Yang.   

Abstract

BACKGROUND: The present article aims to provide accurate estimates of the prevalence, awareness, treatment, and control of hypertension in adults in China. METHODS AND
RESULTS: Data were obtained from sphygmomanometer measurements and an administered questionnaire from 141 892 Chinese adults >/=18 years of age who participated in the 2002 China National Nutrition and Health Survey. In 2002, approximately 153 million Chinese adults were hypertensive. The prevalence was higher among men than women (20% versus 17%; P<0.001) and was higher in successive age groups. Overall, the prevalence of hypertension was higher in urban compared with rural areas in men (23% versus 18%; P<0.01) and women (18% versus 16%; P<0.001). Of the 24% affected individuals who were aware of their condition, 78% were treated and 19% were adequately controlled. Despite evidence to suggest improved levels of treatment in individuals with hypertension over the past decade, compared with estimates from 1991, the ratio of controlled to treated hypertension has remained largely unchanged at 1:4.
CONCLUSIONS: One in 6 Chinese adults is hypertensive, but only one quarter are aware of their condition. Despite increased rates of blood pressure-lowering treatment, few have their hypertension effectively controlled. National hypertension programs must focus on improving awareness in the wider community, as well as treatment and control, to prevent many tens of thousands of cardiovascular-related deaths.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19106390     DOI: 10.1161/CIRCULATIONAHA.108.788166

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  231 in total

1.  Risks and predictors of mild diastolic dysfunction among middle-aged and aged women: a population-based cohort study.

Authors:  J Wu; S Y Yu; D Wo; M M Zhao; L J Zhang; J Li
Journal:  J Hum Hypertens       Date:  2015-08-27       Impact factor: 3.012

2.  Association of obesity categories and high blood pressure in a rural adult Chinese population.

Authors:  Y Zhao; M Zhang; X Luo; L Yin; C Pang; T Feng; Y Ren; B Wang; L Zhang; L Li; H Zhang; X Yang; C Han; D Wu; J Zhou; Y Shen; C Wang; J Zhao; D Hu
Journal:  J Hum Hypertens       Date:  2016-02-25       Impact factor: 3.012

3.  Risk factors for depression among elderly subjects with hypertension living at home in China.

Authors:  Lina Ma; Zhe Tang; Fei Sun; Lijun Diao; Yun Li; Jieyu Wang; Ming Feng; Yuying Qian
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Hyperhomocysteinemia independently associated with the risk of hypertension: a cross-sectional study from rural China.

Authors:  Z Li; X Guo; S Chen; L Zheng; H Yang; G Sun; S Yu; W Li; L Zhou; J Wang; W Hu; Y Sun
Journal:  J Hum Hypertens       Date:  2015-07-09       Impact factor: 3.012

5.  Salt sales survey: a simplified, cost-effective method to evaluate population salt reduction programs--a cluster-randomized trial.

Authors:  Yuan Ma; Feng J He; Nicole Li; Jesse Hao; Jing Zhang; Lijing L Yan; Yangfeng Wu
Journal:  Hypertens Res       Date:  2015-12-10       Impact factor: 3.872

6.  Hypertension prevalence, awareness, treatment, and control in northeast China: a population-based cross-sectional survey.

Authors:  Fu-Liang Zhang; Zhen-Ni Guo; Ying-Qi Xing; Yan-Hua Wu; Hao-Yuan Liu; Yi Yang
Journal:  J Hum Hypertens       Date:  2017-11-27       Impact factor: 3.012

7.  A large-scale cluster randomized trial to determine the effects of community-based dietary sodium reduction--the China Rural Health Initiative Sodium Reduction Study.

Authors:  Nicole Li; Lijing L Yan; Wenyi Niu; Darwin Labarthe; Xiangxian Feng; Jingpu Shi; Jianxin Zhang; Ruijuan Zhang; Yuhong Zhang; Hongling Chu; Andrea Neiman; Michael Engelgau; Paul Elliott; Yangfeng Wu; Bruce Neal
Journal:  Am Heart J       Date:  2013-10-09       Impact factor: 4.749

Review 8.  Gender Differences in Antihypertensive Treatment: Myths or Legends?

Authors:  Maria Lorenza Muiesan; Massimo Salvetti; Claudia Agabiti Rosei; Anna Paini
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-04-22

9.  Causes and outcomes of persistent vegetative state in a Chinese versus American referral hospital.

Authors:  Farrah J Mateen; Jing-Wen Niu; Shan Gao; Shun-Wei Li; Marco Carone; Eelco F M Wijdicks; Wei-Hai Xu
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

10.  Rationales, design and recruitment of the Taizhou Longitudinal Study.

Authors:  Xiaofeng Wang; Ming Lu; Ji Qian; Yajun Yang; Shilin Li; Daru Lu; Shunzhang Yu; Wei Meng; Weimin Ye; Li Jin
Journal:  BMC Public Health       Date:  2009-07-10       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.